A double-blind crossover study to compare the efficacy of three dosage levels of flurbiprofen in the treatment of rheumatoid disease and osteoarthrosis

Clinical Trial

N Cardoe. Curr Med Res Opin. 1977.

. 1977;5(1):99-105.

doi: 10.1185/03007997709108985.

No abstract available

Cited by

Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of day.
Kowanko IC, Pownall R, Knapp MS, Swannell AJ, Mahoney PG. Kowanko IC, et al. Br J Clin Pharmacol. 1981 May;11(5):477-84. doi: 10.1111/j.1365-2125.1981.tb01153.x. Br J Clin Pharmacol. 1981. PMID: 7272159 Free PMC article. Clinical Trial.
Outcome measurement in osteoarthritis clinical trials: the case for standardisation.
Bellamy N, Buchanan WW. Bellamy N, et al. Clin Rheumatol. 1984 Sep;3(3):293-303. doi: 10.1007/BF02032334. Clin Rheumatol. 1984. PMID: 6488707
Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases.
Brogden RN, Heel RC, Speight TM, Avery GS. Brogden RN, et al. Drugs. 1979 Dec;18(6):417-38. doi: 10.2165/00003495-197918060-00001. Drugs. 1979. PMID: 391529 Review.
An analysis of the gastro-intestinal side-effects of non-steroidal anti-inflammatory drugs, with particular reference to comparative studies in man and laboratory species.
Rainsford KD. Rainsford KD. Rheumatol Int. 1982;2(1):1-10. doi: 10.1007/BF00541263. Rheumatol Int. 1982. PMID: 7178760
Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.
Johnson AG, Seideman P, Day RO. Johnson AG, et al. Drug Saf. 1993 Feb;8(2):99-127. doi: 10.2165/00002018-199308020-00002. Drug Saf. 1993. PMID: 8452660 Review.